SQ 14, 225 attenuates the vascular response to norepinephrine in the rat mesenteric arteries
- 1 October 1979
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 25 (15), 1343-1349
- https://doi.org/10.1016/0024-3205(79)90401-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agentProgress in Cardiovascular Diseases, 1978
- INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILUREThe Lancet, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbitsEuropean Journal of Pharmacology, 1977
- Accentuated Vascular and Endocrine Response to Sq 20881 in HypertensionNew England Journal of Medicine, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977
- The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric blood vessels of the ratThe Journal of Physiology, 1965